Quest Diagnostics Incorporated (NYSE:DGX) Q4 2023 Earnings Call Transcript
Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.15, expectations were $2.14.
Quest Diagnostics Inc (DGX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 533,600 | $73,572,768 | +114% | 0.03% | |
| 2. | Alyeska Investment Group Anand Parekh | 375,000 | $51,705,000 | 0.34% | |
| 3. | Bridgewater Associates Ray Dalio | 201,600 | $27,796,608 | -19% | 0.15% |
| 4. | Citadel Investment Group Ken Griffin | 201,424 | $27,772,341 | +170% | 0% |
| 5. | Millennium Management Israel Englander | 175,272 | $24,166,503 | -48% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.51 | 4,000 | Officer | 44,222 | 2014-05-05 | Filing | |
| $50.71 | 2,600 | Director | 5,658 | 2014-02-06 | Filing | |
| $50.70 | 2,400 | Director | 3,058 | 2014-02-06 | Filing | |
| $59.34 | 5,000 | Officer, Director | 68,034 | 2012-08-07 | Filing | |
| $56.89 | 20,000 | Officer, Director | 63,034 | 2012-05-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $125.88 | 1,187 | Officer | 68,412 | 2024-02-29 | Filing | |
| $126.57 | 5,557 | Officer | 69,599 | 2024-02-28 | Filing | |
| $125.88 | 5,611 | Officer | 38,478 | 2024-02-29 | Filing | |
| $126.14 | 661 | Officer | 40,206 | 2024-02-22 | Filing | |
| $126.64 | 2,500 | Director | 16,329 | 2024-02-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,576,201 | $1,871,886,594 | 0.04% | |
| 2. | 10,578,368 | $1,458,545,316 | 0.03% | |
| 3. | 5,330,112 | $734,915,843 | 0.03% | |
| 4. | 3,620,124 | $499,142,720 | 0.34% | |
| 5. | 3,476,628 | $479,357,468 | 0.5% |
News See All
Here's What Makes Quest Diagnostics (DGX) a Great Long-Term Investment
Davis Funds, an investment management firm, released its "Davis New York Venture Fund" third quarter 2023 investor letter, a copy of which can be downloaded here.
Quest Diagnostics Incorporated (NYSE:DGX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Third Quarter 2023 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics Incorporated (NYSE:DGX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Second Quarter 2023 Conference Call. At the request of the company, this call is being recorded. [Operator Instructions].
Quest Diagnostics Incorporated (NYSE:DGX) Q1 2023 Earnings Call Transcript
Operator: Hello, and thank you all for standing by. Welcome to the Quest Diagnostics First Quarter 2023 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2022 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics Fourth Quarter and Full Year 2002 conference call. At the request of the company, this call is being recorded.
10 Quality Stocks With Dividend Yields Over 2%
In this article, we discuss 10 quality stocks with dividend yields over 2%.
5 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat
In this article, we will look at 5 healthcare and biotech stocks to buy amid the monkeypox threat.
10 Companies that Recently Raised Guidance
In this article, we discuss 10 companies that recently raised their guidance.
Billionaire Jeffrey Talpins Just Fled From These 10 Healthcare Stocks
In this article we look at why Billionaire Jeffrey Talpins Just Fled From These 10 Healthcare Stocks.
Billionaire Hedge Funds
